NCT03634007: An ongoing trial by Lexeo Therapeutics
This trial is completed, but has been granted a delay in reporting its results.
It must report results 1 year, 10 months from now.
Full data
| Full entry on ClinicalTrials.gov | NCT03634007 |
|---|---|
| Title | A 52-Week, Multicenter, Phase 1/2 Open-label Study to Evaluate the Safety of LX1001 in Participants With APOE4 Homozygote Alzheimer's Disease |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Nov. 6, 2019 |
| Completion date | Nov. 7, 2024 |
| Required reporting date | Nov. 7, 2027, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | None |